Could high serum neopterin levels serve as a biomarker for patients diagnosed with rosacea, specifically the papulopustular rosacea subtype?
Аннотация
OBJECTIVES
This study aimed to compare serum neopterin and other inflammatory marker levels between patients with rosacea and healthy controls and to investigate the potential role of neopterin in disease diagnosis and severity assessment.
METHODS
Forty drug-naive patients clinically diagnosed with papulopustular rosacea and forty healthy controls were included. The serum levels of neopterin and other inflammatory markers were measured. The Investigator's Global Assessment (IGA) score was used to assess the patient's disease severity.
RESULTS
Serum neopterin, TNF-α, IFN-γ, and CRP levels were significantly higher in patients with papulopustular rosacea than in controls. A positive correlation was found between neopterin, TNF-α, IFN-γ, and IGA scores (r=0.498, 0.523, and 0.432, respectively). ROC curve analysis demonstrated good diagnostic performance for IFN-γ (AUC=0.821), TNF-α (AUC=0.780), and neopterin (AUC=0.747).
CONCLUSIONS
New biochemical markers are needed to assess rosacea severity. Neopterin may be a potential biomarker for rosacea.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.